NEW YORK ( TheStreet) -- Allergan (NYSE: AGN) hit a new 52-week high Thursday as it is currently trading at $94.20, above its previous 52-week high of $93.69 with 1.1 million shares traded as of 3:35 p.m. ET. Average volume has been 1.6 million shares over the past 30 days. Allergan has a market cap of $26.99 billion and is part of the health care sector and drugs industry. Shares are up 6.7% year to date as of the close of trading on Wednesday. Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company has a P/E ratio of 31, above the average drugs industry P/E ratio of 29.7 and above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Allergan as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Allergan Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.